These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7644743)

  • 21. Outcome of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia.
    Fiorella ML; Ross D; Henderson KJ; White RI
    Laryngoscope; 2005 Feb; 115(2):301-5. PubMed ID: 15689755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bilateral closure of the nasal cavity. An original surgical technique of treatment of severe recurrent epistaxis in Rendu-Osler disease].
    Serrano E; Percodani J; Pessey JJ
    Ann Otolaryngol Chir Cervicofac; 1998 Jun; 115(3):169-73. PubMed ID: 9765720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous embolization on hereditary hemorrhagic telangiectasia patients with severe epistaxis.
    Braak SJ; de Witt CA; Disch FJ; Overtoom TT; Westermann JJ
    Rhinology; 2009 Jun; 47(2):166-71. PubMed ID: 19593974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nasal closure as definitive treatment for epistaxis in Rendu-Osler-Weber disease].
    Alonso-Treceño JL; Alonso-Castañeira I; Escapa-Garrachón JM; Moralejo-Martín J; Enterría-González A; Freijanes-Otero J
    Acta Otorrinolaringol Esp; 2008 Oct; 59(8):420-3. PubMed ID: 18928679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Radiotherapy and curietherapy of squamous cell carcinoma of the posterior pharyngeal wall (excluding the nasopharynx)].
    Chenal C; Julienne V; Fleury F; Desprez P
    Bull Cancer Radiother; 1996; 83(1):54-9. PubMed ID: 8679282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rendu-Osler disease treated by endonasal radiotherapy (evaluation of 62 cases)].
    Maylin C; Sauvage JP; Baillet F; Chassagne D; Pierquin B
    Ann Otolaryngol Chir Cervicofac; 1976; 93(1-2):95-102. PubMed ID: 970864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
    Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
    Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
    HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [High-dose-rate brachytherapy. The indications, technic and preliminary results].
    Orecchia R; Ragona R; Anglesio S; Tessa M; Del Mastro E; Sannazzari GL
    Minerva Med; 1996; 87(1-2):1-7. PubMed ID: 8610019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary haemorrhagic telangiectasia.
    Sharathkumar AA; Shapiro A
    Haemophilia; 2008 Nov; 14(6):1269-80. PubMed ID: 19141168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Rendu-Osler-Weber disease].
    Sys L; van den Hoogen FJ
    Ned Tijdschr Tandheelkd; 2005 Sep; 112(9):336-9. PubMed ID: 16184912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
    Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
    Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [treatment of an epistaxis using a bilateral nasolabial flap in Osler-Rendu disease].
    Benassayag C; Boudard P; Portmann D
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):305-7. PubMed ID: 8638056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Surgical treatment of epistaxis in Osler-Rendu-Weber disease].
    Stastný B; Kroslák M
    Cesk Otolaryngol; 1981 Jan; 30(1):53-6. PubMed ID: 7214573
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rendu-Osler-Weber disease. Report of a clinical case].
    Staffa F; Bartone M; Mancuso G; Mattioli PL; Pujia A; Gnasso A
    Minerva Med; 1996 Oct; 87(10):471-4. PubMed ID: 8992409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
    Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Brachytherapy for prostate cancer: high dose rate or low-dose rate?].
    Cosset JM; Haie-Meder C
    Cancer Radiother; 2005 Dec; 9(8):610-9. PubMed ID: 16226473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
    Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
    Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bevacizumab nasal spray: Noninvasive treatment of epistaxis in patients with Rendu-Osler disease.
    Guldmann R; Dupret A; Nivoix Y; Schultz P; Debry C
    Laryngoscope; 2012 May; 122(5):953-5. PubMed ID: 22447341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.